HR 8000 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend the Controlled Substances Act to schedule synthetic 7- hydroxymitragynine as a Schedule I controlled substance.
Summary
The bill amends the Controlled Substances Act to classify synthetic 7-hydroxymitragynine as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess. Schedule I is the most restrictive category for controlled substances, reserved for drugs considered to have a high potential for abuse and no accepted medical use. The bill specifically includes synthetic equivalents of 7-hydroxymitragynine in this scheduling but excludes 7-hydroxymitragynine naturally occurring in kratom (Mitragyna speciosa), leaving the plant and its natural compounds unscheduled.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
2 cosponsors
Money behind the sponsor
Top reported contributors to Gus M. Bilirakis’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Gus M. Bilirakis → · Outside spending →
Actions (2)
- Mar 19, 2026 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Mar 19, 2026 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE HOUSE OF REPRESENTATIVES
March 19, 2026
Mr. Bilirakis introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend the Controlled Substances Act to schedule synthetic 7- hydroxymitragynine as a Schedule I controlled substance.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “End Needless Distribution of 7-OH Act” or the “END 7-OH Act”.
SEC. 2. SCHEDULING OF 7-HYDROXYMITRAGYNINE.
Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended by adding at the end of subsection (b) of such schedule the following:
“(23) 7-hydroxymitragynine—
“(A) including its synthetic equivalents; but
“(B) not including 7-hydroxymitragynine naturally contained in the plant of the genus and species name: Mitragyna speciosa Korth, also known as kratom.”. <all>
Comments